Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.5800
-0.0150 (-2.52%)
Nov 11, 2026, 4:10 PM AEDT
Orthocell Market Cap
Orthocell has a market cap or net worth of 157.99 million as of November 10, 2026. It is the 24,452nd most valuable company in the world and the 514th biggest in Australia. Its market cap has decreased by 47.21% in one year.
Market Cap
157.99M
Enterprise Value
115.01M
Revenue
11.41M
Global Rank
Country Rank
#514 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 157.99M, an increase of 431.95%. That is a compound annual growth rate of 14.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 157.99M | -46.33% |
| Dec 31, 2025 | 294.37M | -9.37% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tetratherix | 331.61M |
| Racura Oncology | 307.83M |
| BLS Pharmaceuticals | 211.88M |
| Starpharma Holdings | 196.69M |
| Actinogen Medical | 184.70M |
| Paradigm Biopharmaceuticals | 153.48M |
| Dimerix | 132.09M |
| Nyrada | 123.80M |